Sex-biased adaptive immune regulation in cancer development and therapy
Johanna M. Schafer(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Zihai Li(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Qin Ma(The Ohio State University), Debasish Sundi(The Ohio State University), Chelsea Bolyard(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Katharine A. Collier(The Ohio State University), Yuanquan Yang(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Tong Xiao(Shenyang University of Technology), Hany Abdel-Hafiz(University of Arizona), Dongjun Chung(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Yuzhou Chang(Shanghai Institute of Measurement and Testing Technology), Hyunwoo Kwon(Medical University of South Carolina), Xue Li(Boston Children's Hospital), Dan Theodorescu(University of Arizona)
Cited by 30
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Advances in bladder cancer biology and therapy
|Nature reviews. Cancer|2020|783
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
|Molecular & Cellular Proteomics|2010|537
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
|Science Translational Medicine|2010|335